Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0003 (60.00%)
At close: Dec 19, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Gene Control Medicines
9.94M
Log In
Log In
Log In
Log In
Upgrade
Gene Control Medicines Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
9.94M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade